Aequitas Research - Wiwynn Corp. (6669) Wiwynn Corp Placement

Report

Aequitas Research

Clarence Chu

EUR 88.49 For Business Accounts Only

Wiwynn Corp Placement

Wistron aims to raise around US$204m (NT$5.8bn) via selling 3.3% of its stake in subsidiary, Wiwynn Corp. This would not be a clean-up.

The timing is curious given Wiwynn having just announced its plans to offer up to 17m new shares in a primary follow-on offer. While not explicitly stated, the selldown could also be geared either towards capex for its global expansion plans or for restructuring of its subsidiary holdings.

In this note, we will talk about the firm’s track record and run the deal through our ECM framework.

21/03/2022 1 EN

Underlying

Wiwynn Corp.

Wiwynn Corp is a Taiwan-based company mainly engaged in the research, development, design, manufacture, testing and distribution of servers for cloud services and Hyperscale Data Centers. The Company's products mainly include computers and peripheral equipment, data storage media, electrical equipment and audio-visual electronic products, information software and others. The Company mainly distributes its products in Taiwan, Americas, Europe, Asia and other regions.

See profile

TW0006669005 Taiwan Stock Exchange Chinese Taipei

Provider

Aequitas Research

Aequitas Research is a leading ECM research firm with a focus on IPOs and placements/follow-on offerings across the Asia Pacific with deal size of over USD100m.

Since 2015, we have covered 400+ IPOs and 450+ placements with a hit rate of 73% and 65%, respectively. We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic analysis.

Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis. We also provide a more quant driven analysis on placement/follow-on offerings.

Markets that we cover include:
Hong Kong,
China ADRs,
India,
Japan,
Australia, and
ASEAN.

See profile

Analysts

Clarence Chu

Other Reports on these Companies

TheScreener

With a more favourable environment, WIWYNN CORPORATION improves to Slightly Positive

WIWYNN CORPORATION (TW), a company active in the Computer Hardware industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date November 2, 2021, the closing price was TWD 886.00 and its potential was estimated at TWD 1,032.89.

Free Trial

November 3, 2021 November 3, 2021 6 EN

Vermilion Research

Vermilion Int'l Compass: Global Equity Strategy

Lower High Forming? Major global indexes are showing waning upside momentum and we believe near-term consolidation is likely. This is supported by the charts and the idea that consolidation makes sense following the massive gains off of the March lows. We also believe that the market is in a â€œwait-and-seeâ€ phase as it relates to states and countries re-opening. A resolution of this consolidation period above resistance (bullish) or below support (bearish) will tell us where the major global averages are headed next. Â· Wedge/Uptrend Breakdowns. Last week we highlighted potential ...

EUR 44.25

May 7, 2020 May 7, 2020 21 EN

Onewo Space-Tech Pre-IPO

Onewo Space-Tech (OST) aims to raise around US$2bn in its Hong Kong IPO. OST is a property management service provider in China, primarily owned by China Vanke. As per Frost & Sullivan, in 2020, amongst the residential community service providers in the market, OST ranked first in terms of revenue. It also ranked first in the commercial space integrated services market in China. As of end FY21, it has a footprint in 153 cities in 32 provinces across China with 89% of total GFA under management for residential properties located in first-tier, new first-tier and second-tier cities. OST has m...

EUR 88.49

July 27, 2022 July 27, 2022 1 EN

Sumeet Singh

Sumeet Singh

Legend Biotech Follow-on Offering

Legend Biotech, a non-wholly owned subsidiary of Hong Kong-listed GenScript, is planning to raise up to US$250m in its follow-on offering. The company last raised cash in Dec 2021 in a similar sized deal, which ended up doing very well after a sharp share price correction. In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

EUR 88.49

July 26, 2022 July 26, 2022 1 EN

Clarence Chu

Clarence Chu

Xtep International Placement

Group Success Investments is looking to raise up to US$133m by trimming its holdings in Xtep International. We can’t say that the deal is expected and short interest on the stock hasn’t been creeping up as well. While the deal won’t be a large one, representing just 5.7 days of three month ADV, the firm’s last deal hasn’t done well.

EUR 88.49

July 26, 2022 July 26, 2022 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Wiwynn Corp Placement

With a more favourable environment, WIWYNN CORPORATION improves to Slightly Positive

Vermilion Int'l Compass: Global Equity Strategy

Onewo Space-Tech Pre-IPO

Legend Biotech Follow-on Offering

Xtep International Placement

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe